KeyBank National Association’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-13,378
Closed -$290K 1055
2018
Q3
$290K Sell
13,378
-3,736
-22% -$78.1K ﹤0.01% 913
2018
Q2
$302K Hold
17,114
﹤0.01% 875
2018
Q1
$360K Sell
17,114
-4,791
-22% -$93.3K ﹤0.01% 840
2017
Q4
$317K Buy
21,905
+339
+2% +$5.23K ﹤0.01% 876
2017
Q3
$340K Sell
21,566
-5,985
-22% -$87.8K ﹤0.01% 886
2017
Q2
$342K Buy
27,551
+7,503
+37% +$87K ﹤0.01% 919
2017
Q1
$326K Hold
20,048
﹤0.01% 951
2016
Q4
$303K Buy
+20,048
New +$283K ﹤0.01% 961
2016
Q3
Sell
-5,554
Closed -$216K 1179
2016
Q2
$216K Buy
+5,554
New +$200K ﹤0.01% 1026
2016
Q1
Sell
-6,455
Closed -$347K 1150
2015
Q4
$347K Sell
6,455
-2,324
-26% -$117K ﹤0.01% 906
2015
Q3
$352K Sell
8,779
-4,379
-33% -$143K ﹤0.01% 904
2015
Q2
$420K Buy
13,158
+2,135
+19% +$54.1K ﹤0.01% 889
2015
Q1
$263K Buy
+11,023
New +$247K ﹤0.01% 1059

Other funds holding ITCI

KeyBank National Association's ITCI Position: Q4 2018 in Review

KeyBank National Association sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2018, closing a stake of 13,378 shares — an estimated $290K sold.

KeyBank National Association first reported a position in ITCI in Q1 2015 and held it in 13 quarters. The position peaked at $420K in Q2 2015. 127 funds tracked by Wall St. Rank hold ITCI as of Q4 2018.

  • KeyBank National Association reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2018 after selling out during the quarter.
  • KeyBank National Association sold 13,378 Intra-Cellular Therapies Inc. shares in Q4 2018, an estimated $290K.
  • KeyBank National Association first reported a position in Intra-Cellular Therapies Inc. in Q1 2015 and held it in 13 quarters.
  • KeyBank National Association's Intra-Cellular Therapies Inc. position peaked at $420K in Q2 2015.
  • 127 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2018.

Based on KeyBank National Association's 13F filing for Q4 2018, filed 30 Jan 2019.